Selecta Biosciences, Inc.
News
Selecta Biosciences (NASDAQ:SELB) Earns "Buy" Rating from HC Wainwright
Zolmax HC Wainwright reaffirmed their buy rating on shares of Selecta Biosciences (NASDAQ:SELB Free Report) in a research note published on Friday morning, Benzinga reports. The brokerage currently has a $5.00 target price on the stock. A number of other research analysts also recently issued reports on ...\n more…
Selecta Biosciences (NASDAQ:SELB) PT Lowered to $4.00
Ticker Report Selecta Biosciences (NASDAQ:SELB Free Report) had its price objective decreased by Needham Company LLC from $5.00 to $4.00 in a research note released on Friday, Benzinga reports. Needham Company LLC currently has a buy rating on the stock. Other equities research analysts have ...\n more…
Selecta Biosciences (NASDAQ:SELB) Rating Lowered to Market Perform at Leerink Partnrs
Ticker Report Leerink Partnrs downgraded shares of Selecta Biosciences (NASDAQ:SELB Free Report) from an outperform rating to a market perform rating in a research note published on Friday, PriceTargets.com reports. Several other analysts have also issued reports on SELB. SVB Leerink restated a market ...\n more…
Selecta Biosciences (NASDAQ:SELB) Downgraded by Leerink Partnrs
Ticker Report Leerink Partnrs downgraded shares of Selecta Biosciences (NASDAQ:SELB Free Report) from an outperform rating to a market perform rating in a research note issued to investors on Friday morning, PriceTargets.com reports. Other equities analysts also recently issued research reports about the ...\n more…
Selecta Biosciences (NASDAQ:SELB) Announces Quarterly Earnings Results, Beats Estimates By $0.05 EPS
Ticker Report Selecta Biosciences (NASDAQ:SELB Get Free Report) released its earnings results on Thursday. The company reported ($0.07) earnings per share (EPS) for the quarter, topping analysts’...\n more…
Selecta Biosciences (NASDAQ:SELB) Receives Market Perform Rating from SVB Leerink
Ticker Report Selecta Biosciences (NASDAQ:SELB Get Free Report)s stock had its market perform rating reissued by equities researchers at SVB Leerink in a note issued to investors on...\n more…